ClinicalTrials.gov has a full list of NIAID-funded clinical
studies related to RSV. NIAID conducts and supports basic
research on RSV to improve our understanding of the virus and
how it causes disease, as well as factors in animals and humans
that affect susceptibility to RSV infection. Scientists in NIAID
labs and in universities and medical research centers across the
United States work together to translate this knowledge into
new, safe, and effective ways to treat and prevent RSV. NIAID
funds several research activities to evaluate potential new
therapies for RSV. For example, a recent study supported in part
by NIAID unveiled a possible role of the anti-influenza drug
oseltamivir in treating RSV infection. The study, published in
the March 2007 issue of the Journal of Immunology, found that
the drug decreased RSV-induced weight loss and inhibited RSV
clearance in mice, suggesting that it may be effective in
moderating RSV symptoms in humans. Scientists in the NIAID
Laboratory of Allergic Diseases have d